25 AEFI reports on fatalities found not linked to Covid vaccines
National Pharmaceutical Regulatory Agency says 31 more cases are still being investigated.
Copy URLThe National Pharmaceutical Regulatory Agency says 131 cases of the 1,526 AEFI reports of Covid-19 booster doses registered as of April 1 are classified as serious. – The Malaysian Insight file pic, April 6, 2022.THE Covid-19 Vaccine Pharmacovigilance Special Committee’s (JFK) evaluation of 25 reports of adverse events following immunisation (AEFI), which involved deaths among recipients of the booster dose, found that the fatalities were not related to the vaccine received.
National Pharmaceutical Regulatory Agency (NPRA) director Dr Roshayati Mohamad Sani said the 25 were out of the 56 AEFI reports involving deaths among recipients of the booster dose that were received by the agency for investigation and evaluation.